BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31109130)

  • 1. Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization.
    Hong KO; Ahn CH; Yang IH; Han JM; Shin JA; Cho SD; Hong SD
    Molecules; 2019 May; 24(10):. PubMed ID: 31109130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
    Wang H; Sun W; Zhang WZ; Ge CY; Zhang JT; Liu ZY; Fan YZ
    PLoS One; 2014; 9(5):e96982. PubMed ID: 24811250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity.
    Yeh CB; Hsieh MJ; Hsieh YH; Chien MH; Chiou HL; Yang SF
    PLoS One; 2012; 7(2):e31055. PubMed ID: 22363545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
    Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
    Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
    BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells.
    Chen YJ; Shieh CJ; Tsai TH; Kuo CD; Ho LT; Liu TY; Liao HF
    Anticancer Drugs; 2005 Mar; 16(3):293-9. PubMed ID: 15711181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
    Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
    Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway.
    Wang HC; Chu YL; Hsieh SC; Sheen LY
    Environ Toxicol; 2017 Nov; 32(11):2352-2359. PubMed ID: 28741790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
    Mei L; Sang W; Cui K; Zhang Y; Chen F; Li X
    Cancer Sci; 2019 Feb; 110(2):582-595. PubMed ID: 30520540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells.
    Chen YJ; Chang WM; Liu YW; Lee CY; Jang YH; Kuo CD; Liao HF
    Chem Biol Interact; 2009 Oct; 181(3):440-6. PubMed ID: 19616522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
    Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
    Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
    Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
    Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.
    Peng C; Li Z; Niu Z; Niu W; Xu Z; Gao H; Niu W; Wang J; He Z; Gao C; Lin P; Agrez M; Zhang Z; Niu J
    Sci Rep; 2016 Feb; 6():20500. PubMed ID: 26846153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
    Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR
    J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway.
    Sun J; Luo Q; Liu L; Yang X; Zhu S; Song G
    Toxicology; 2017 Jun; 384():1-10. PubMed ID: 28395993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism].
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):271-4. PubMed ID: 15312360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.